How do the hormonal side effects of the NuvaRing differ from the Annovera vaginal system over a twelve-month usage cycle for women with a history of migraines?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
How do the hormonal side effects of the NuvaRing differ from the Annovera vaginal system over a twelve-month usage cycle for women with a history of migraines?
3 real searches · 1 real-search pass
NuvaRing prescribing information headache migraine adverse reactions etonogestrel ethinyl estradiol label 2025Google ↗
OBSERVEDConsequence
Annovera prescribing information migraine headache adverse reactions segesterone ethinyl estradiol label 2025Google ↗
OBSERVEDConsequence
CDC U.S. Medical Eligibility Criteria 2024 migraine with aura combined hormonal contraceptivesGoogle ↗
OBSERVEDConsequence
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (3)
Classes come from the query-classifier (a local Laya model). 3 of 3 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
ChatGPT3 real searches · gpt-6
NuvaRing prescribing information headache migraine adverse reactions etonogestrel ethinyl estradiol label 2025 Google ↗
Annovera prescribing information migraine headache adverse reactions segesterone ethinyl estradiol label 2025 Google ↗
CDC U.S. Medical Eligibility Criteria 2024 migraine with aura combined hormonal contraceptives Google ↗
- These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)Initial U.S. Approval: 2001 · dailymed.nlm.nih.gov
- DailyMed - ANNOVERA- segesterone acetate and ethinyl estradiol ring · dailymed.nlm.nih.gov
- DailyMed - NUVARING- etonogestrel and ethinyl estradiol insert, extended release · dailymed.nlm.nih.gov
- Appendix A: Summary of Classifications for U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 | Contraception · cdc.gov
- Appendix D: Classifications for Combined Hormonal Contraceptives | Contraception · cdc.gov
- These highlights do not include all the information needed to use ANNOVERA safely and effectively. See full prescribing information for ANNOVERA ANNOVERA® (segesterone acetate and ethinyl estradiol) vaginal ring Initial U.S. Approval: 2018 · dailymed-beta.nlm.nih.gov
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 | Contraception · cdc.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
NuvaRing prescribing information headache migraine adverse reactions etonogestrel ethinyl estradiol label 2025 OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 | |
Annovera prescribing information migraine headache adverse reactions segesterone ethinyl estradiol label 2025 OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 | |
CDC U.S. Medical Eligibility Criteria 2024 migraine with aura combined hormonal contraceptives OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 |